Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

C4 THERAPEUTICS, INC.

(CCCC)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

C4 Therapeutics : Stifel Starts C4 Therapeutics at Hold With $45 Price Target

09/30/2021 | 07:26am EST


ę MT Newswires 2021
All news about C4 THERAPEUTICS, INC.
11/23BofA Securities Starts C4 Therapeutics at Buy With $54 Price Target
MT
11/10C4 Therapeutics Reports Recent Business Highlights and Third Quarter 2021 Financial Res..
PU
11/10C4 THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and ..
AQ
11/10C4 Therapeutics Reports Recent Business Highlights and Third Quarter 2021 Financial Res..
GL
10/28BRD9 TPD Summit Presentation
PU
10/28CFT8919 TPD Summit Presentation
PU
10/14C4 THERAPEUTICS : SVB Leerink Starts C4 Therapeutics at Outperform with $67 Price Target
MT
10/05INSIDER SELL : C4 Therapeutics
MT
09/30C4 THERAPEUTICS : Stifel Starts C4 Therapeutics at Hold With $45 Price Target
MT
09/24INSIDER SELL : C4 Therapeutics
MT
More news
Analyst Recommendations on C4 THERAPEUTICS, INC.
More recommendations
Financials (USD)
Sales 2021 33,0 M - -
Net income 2021 -96,9 M - -
Net cash 2021 378 M - -
P/E ratio 2021 -17,4x
Yield 2021 -
Capitalization 1 748 M 1 748 M -
EV / Sales 2021 41,5x
EV / Sales 2022 47,8x
Nbr of Employees 99
Free-Float 87,4%
Chart C4 THERAPEUTICS, INC.
Duration : Period :
C4 Therapeutics, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends C4 THERAPEUTICS, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 9
Last Close Price 36,65 $
Average target price 59,67 $
Spread / Average Target 62,8%
EPS Revisions
Managers and Directors
Andrew J. Hirsch President, Chief Executive Officer & Director
Lauren White Treasurer, Chief Financial & Accounting Officer
Marc A. Cohen Executive Chairman
Adam S. Crystal Chief Medical Officer
Stewart Fisher Chief Scientific Officer
Sector and Competitors
1st jan.Capi. (M$)
C4 THERAPEUTICS, INC.10.62%1 782
MODERNA, INC.215.53%133 648
LONZA GROUP AG29.85%59 443
IQVIA HOLDINGS INC.46.26%50 064
SEAGEN INC.-3.22%30 994
CELLTRION, INC.-40.81%24 431